SK bioscience Co.,Ltd. (302440.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−23.3x

Market Cap

KRW 2.95T

MomentumView details →

1D Return

+0.80%

YTD Return

−21.37%

RSI (14)

54.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−23.3x

Market Cap

KRW 2.95T

RSI (14)

54.1

MomentumView details →

1D Return

+0.80%

YTD Return

−21.37%

ProfitabilityView details →

Gross Margin

10.13%

Net Margin

−12.03%

EBITDA Margin

−19.06%

ROE (TTM)

−4.54%

ROA (TTM)

−2.66%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

+23.25%

EPS YoY

−57.46%

FCF YoY

+22.41%

Revenue CAGR 3Y

+12.56%

EPS CAGR 3Y

−2.59%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−KRW 309.76

EPS Surprise

9.08%

Beats (12Q)

1/12

Next Q EPS Est

−KRW 453.86

Avg Surprise (4Q)

9.08%

Rev Surprise

−13.50%

Capital & dividendView details →

Debt/Equity

0.31x

Current Ratio

3.60x

Quick Ratio

2.95x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

659.27B

Net Income (TTM)

−79.34B

Op. CF (TTM)

911.03M

Next earningsOct 22, 2026 →

Latest newsMore news →

No recent news for 302440.KS.

Similar companies

Hugel, Inc.145020.KQ D&D Pharmatech347850.KQ Voronoi, Inc.310210.KQ LigaChem Biosciences Inc.141080.KQ Peptron, Inc.087010.KQ PharmaResearch Co., Ltd.214450.KQ Find similar companies →

Latest newsMore news →

No recent news for 302440.KS.